91 related articles for article (PubMed ID: 3341785)
21. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
Kang M; Zhou L; Lin P
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
[TBL] [Abstract][Full Text] [Related]
23. [Recognition of tumorous and non-tumorous cells in cytological studies of serous fluids].
Kurbatova TI
Vopr Onkol; 1968; 14(11):29-36. PubMed ID: 5729483
[No Abstract] [Full Text] [Related]
24. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
25. [The locoregional treatment of neoplastic ascites with interferon-beta].
Cappelli R; Gotti G
Recenti Prog Med; 1992 Feb; 83(2):82-4. PubMed ID: 1502425
[TBL] [Abstract][Full Text] [Related]
26. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863
[TBL] [Abstract][Full Text] [Related]
27. [A preliminary report on the treatment of pleural carcinomatosis with SMANCS].
Kimura M; Kaneda H; Kume S; Matsushita H; Inoue M; Kai M; Takeuchi H; Uemura K
Gan To Kagaku Ryoho; 2001 Jul; 28(7):1023-5. PubMed ID: 11478133
[TBL] [Abstract][Full Text] [Related]
28. Pleural effusion in lung cancer.
Sahn SA
Clin Chest Med; 1982 May; 3(2):443-52. PubMed ID: 7047062
[TBL] [Abstract][Full Text] [Related]
29. Pleural effusion in breast cancer: influence upon clinical course and survival.
Singer TS; Sulkes A; Biran S
Chemioterapia; 1986 Feb; 5(1):66-9. PubMed ID: 3955787
[TBL] [Abstract][Full Text] [Related]
30. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
[TBL] [Abstract][Full Text] [Related]
31. Intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Rosso R; Rimoldi R; Salvati F; De Palma M; Cinquegrana A; Nicolò G; Ardizzoni A; Fusco U; Capaccio A; Centofanti R
Oncology; 1988; 45(3):253-6. PubMed ID: 2453008
[TBL] [Abstract][Full Text] [Related]
32. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
[TBL] [Abstract][Full Text] [Related]
33. [Results of phase III clinical trial of Pseudomonas jinanensis vaccine injection (PVI) in the treatment of malignant pleural effusion].
Wang J; Zhang H; Wang Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):458-60. PubMed ID: 8698003
[TBL] [Abstract][Full Text] [Related]
34. Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients.
Gebbia N; Mannino R; Di Dino A; Maxhouni L; Bellone N; Cinque L; Liuzza A; La Motta P; Cannata G; Gulotta G
Anticancer Res; 1994; 14(2B):739-45. PubMed ID: 7516642
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic analysis of malignant peritoneal effusions from gastric cancer].
Yamada S; Takeda T; Takaso K; Shinzawa H; Matsuda T; Saito H
Gan No Rinsho; 1983 Feb; 29(2):A-8, 125-8. PubMed ID: 6876400
[TBL] [Abstract][Full Text] [Related]
36. Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8.
Wakely PE; Menezes G; Nuovo GJ
Mod Pathol; 2002 Sep; 15(9):944-50. PubMed ID: 12218212
[TBL] [Abstract][Full Text] [Related]
37. [Carcinoembryonic antigen in ascites and pleural effusions].
Lirzin P; Zeitoun P; Vandromme L; Salas H
Gastroenterol Clin Biol; 1984 Mar; 8(3):222-7. PubMed ID: 6714557
[TBL] [Abstract][Full Text] [Related]
38. [Skin reaction to OK-432 and its dosage for locoregional administration].
Yamaguchi Y; Noma K; Miyahara E; Funakoshi M; Takashima I; Kawami H; Sawamura A; Toge T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2108-10. PubMed ID: 7944414
[TBL] [Abstract][Full Text] [Related]
39. [Two cases of malignant effusion treated successfully by loco-regional administration of carboplatin].
Takahashi J; Kinomura S; Abe Y; Yoshioka S; Yambe T; Ono S; Ito H; Fukuda H; Yamada K; Sato T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2817-20. PubMed ID: 7993120
[TBL] [Abstract][Full Text] [Related]
40. [Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant cells in ascites and pleural effusion].
Munker R; Darsow M; Stötzer O; Kremer JP; Mezger J
Med Klin (Munich); 1994 May; 89(5):248-51. PubMed ID: 8052178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
